Abstract:The persistence of cells latently infected with HIV-1, named the latent reservoir, is the major barrier to HIV-1 eradication, and the formation and maintenance of the latent reservoir might be exacerbated by activation of the immunoinhibitory pathway and dysfunction of CD8(+) T cells during HIV-1 infection. Our previous findings demonstrated that prophylactic vaccination combined with PD-1 blockade generated distinct immune response profiles and conferred effective control of highly pathogenic SIVmac239 infection in rhesus macaques. However, to our surprise, herein we found that a therapeutic vaccination in combination with PD-1 blockade resulted in activation of the viral reservoir, faster viral rebound after treatment interruption, accelerated AIDS progression, and, ultimately, death in chronically SIV-infected macaques after antiretroviral therapy (ART) interruption. Our study further demonstrated that the SIV provirus was preferentially enriched in PD-1(+)CD4(+) T cells due to their susceptibility to viral entry, potent proliferative ability, and inability to perform viral transcription. In addition, the viral latency was effectively reactivated upon PD-1 blockade. Together, these results suggest that PD-1 blockade may be a double-edged sword for HIV-1 immunotherapy and provide important insight toward the rational design of immunotherapy strategies for an HIV-1 cure. IMPORTANCE As it is one of the most challenging public health problems, there are no clinically effective cure strategies against HIV-1 infection. We demonstrated that prophylactic vaccination combined with PD-1 blockade generated distinct immune response profiles and conferred better control of highly pathogenic SIVmac239 infection in rhesus macaques. In the present study, to our surprise, PD-1 blockade during therapeutic vaccination accelerated the reactivation of latent reservoir and AIDS progression in chronically SIV-infected macaques after ART interruption. Our study further demonstrated that the latent SIV provirus was preferentially enriched in PD-1(+)CD4(+) T cells because of its susceptibility to viral entry, inhibition of SIV transcription, and potent ability of proliferation, and the viral latency was effectively reactivated by PD-1 blockade. Therefore, PD-1 blockade might be a double-edged sword for AIDS therapy. These findings provoke interest in further exploring novel treatments against HIV-1 infection and other emerging infectious diseases.

Towards a New Combination Therapy with Vectored Immunoprophylaxis for HIV: Modeling "shock and Kill" Strategy.

Research progress on HIV latency-reversing agents and its mechanism

Modeling HIV Dynamics Under Combination Therapy with Inducers and Antibodies

A New Mathematical Model for Assessing Therapeutic Strategies for HIV Infection

Modeling the Cytotoxicity of Latency Reversal Agents Reveals the Ineffectiveness of the 'shock and Kill' Strategy

Modeling of HIV-1 Infection: Insights to the Role of Monocytes/Macrophages, Latently Infected T4 Cells, and HAART Regimes

A Piecewise Model of Virus-Immune System with Two Thresholds

Models of increased latent HIV reservoir turnover prior to cART initiation imply novel clearance strategies

HIV Infection Dynamics with Broadly Neutralizing Antibodies and CTL Immune Response

Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1

Global Stability and Persistence of HIV Models with Switching Parameters and Pulse Control

Pulse HIV Vaccination: Feasibility for Virus Eradication and Optimal Vaccination Schedule.

An Efficient Therapy Strategy under a Novel HIV Model

Dynamics of a New HIV Model with the Activation Status of Infected Cells

A Novel Therapeutic Vaccination Delays Cart-Resistant Hiv-1 Reservoir Rebound in Hiv-1 Infected Humanized Mice

Piecewise immunosuppressive infection model with viral logistic growth and effector cell-guided therapy

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1

Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection

A Piecewise Model of Virus-Immune System with Effector Cell-Guided Therapy

HIV Infection Dynamics and Viral Rebound: Modeling Results from Humanized Mice.

Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy